Effectdossier · gearchiveerd kwartaal
PRVA
Privia Health Group, Inc. · Healthcare · Medical - Healthcare Information Services
15Gevolgde houders
+1Δ houders
53.64MGehouden aandelen
$1.23BGerapporteerde waarde
+1Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +7.1% ·
aandelenstroom -1.7% ·
netto nieuwe posities +6.7%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 102 | +2 | 79.64M | $2.05B | +6 | −4 |
| Q1 2026 | 103 | +3 | 75.09M | $1.54B | +5 | −3 |
| Q4 2025 | 100 | 0 | 81.47M | $1.93B | +1 | — |
| Q3 2025 | 20 | +3 | 56.69M | $1.41B | +4 | −2 |
| Q2 2025 | 15 | +1 | 53.64M | $1.23B | +1 | — |
| Q1 2025 | 11 | -2 | 10.38M | $233.04M | — | −2 |
| Q4 2024 | 13 | 0 | 10.98M | $214.67M | — | — |
| Q3 2024 | 12 | 0 | 8.05M | $146.53M | +1 | −1 |
| Q2 2024 | 12 | — | 11.51M | $200.04M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 18.73M | — | $430.89M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 13.98M | — | $321.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 13.98M | — | $321.51M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Fidelity (FMR) ✦ | 13.98M | — | $321.51M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 13.98M | — | $321.51M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Fidelity (FMR) ✦ | 13.98M | — | $321.51M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 11.49M | — | $264.30M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 11.49M | — | $264.30M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passief) | 11.49M | — | $264.30M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (passief) | 11.49M | — | $264.30M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | The Vanguard Group ✦ (passief) | 11.49M | — | $264.30M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (passief) | 4.17M | +1.5% | $95.93M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | Geode Capital Management ✦ (passief) | 2.66M | +6.3% | $61.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Geode Capital Management ✦ (passief) | 2.66M | +6.3% | $61.09M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Millennium Management ✦ | 801.06K | +131.6% | $18.42M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Renaissance Technologies ✦ | 579.10K | +86.6% | $13.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 506.17K | -7.4% | $11.64M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 506.17K | -7.4% | $11.64M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 216.96K | -88.4% | $4.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 216.96K | -88.4% | $4.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 216.96K | -88.4% | $4.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Two Sigma Investments ✦ | 192.93K | +2.0% | $4.44M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Marshall Wace ✦ | 92.90K | -74.4% | $2.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 40 | Marshall Wace ✦ | 92.90K | -74.4% | $2.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 41 | Marshall Wace ✦ | 92.90K | -74.4% | $2.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 42 | T. Rowe Price ✦ | 92.32K | +17.8% | $2.12M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 55.30K | +35.6% | $1.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 55.30K | +35.6% | $1.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 55.30K | +35.6% | $1.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 55.30K | +35.6% | $1.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Gotham Asset Management ✦ | 38.65K | Nieuw | $888,835 | 0.0% | New | 1 | SEC ↗ |
| 48 | Norges Bank ✦ (passief) | 31.66K | 0.0% | $728,295 | 0.0% | Held | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Gotham Asset Management | $888,835 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 291 houders, 120.95M aandelen, $2.38B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API